Effects of nintedanib on disease progression and safety in Japanese patients with progressive fibrosing interstitial lung diseases: Further subset analysis from the whole INBUILD trial.
暂无分享,去创建一个
Y. Inoue | Y. Nishioka | T. Suda | T. Ogura | A. Azuma | N. Inase | K. Rohr | Ayako Takizawa | Masaki Okamoto | Tomohiro Ito